Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Pantoprazole Teva 40 mg maagsapresistente tabletten, Mycophenolate mofetil Sandoz 500 mg Film-coated Tablets, Mycophenolate Mofetil Accord 500 mg plėvele dengtos tabletės, CellCept 500 mg film-coated tablets
Disc Medicine
Post Transplantation Patients
1 trial -
Prednisolone 5mg Soluble Tablets, Certican 0,75 mg tablety, Mycofenolaat mofetil Sandoz 250 mg, capsules, hard, Envarsus 0.75 mg prolonged-release tablets, Simulect 20 mg powder and solvent for solution for injection or infusion, Ciclosporine Teva 25 mg, zachte capsules
Disc Medicine
kidney transplant
1 trial -
Qvar
Teva Pharma GmbH
Asthma
2 trials -
Qvar® (beclometasone dipropionate HFA)
Teva Pharma GmbH
Asthma
1 trial -
Rasagiline
Teva Pharma GmbH
Parkinson's Disease
5 trials -
Rasagiline
Teva Pharma GmbH
Sleep Disturbances
1 trial -
Rasagiline
Teva Pharma GmbH
Depressive Symptoms
1 trial -
Rasagiline Mesylate
Teva Pharma GmbH
Parkinson's Disease
8 trials -
Rasagiline/Placebo
Teva Pharma GmbH
Parkinson's Disease
1 trial -
Reslizumab
Teva Pharma GmbH
Asthma
5 trials -
Reslizumab
Teva Pharma GmbH
Asthma; Eosinophilic
1 trial -
SCE-B
Teva Pharma GmbH
Nocturnal Vasomotor Symptoms
1 trial -
Shared Solutions® plus MS Center v. Shared Solutions®
Teva Pharma GmbH
Multiple Sclerosis
1 trial -
T-jet® containing TevTropin®
Teva Pharma GmbH
Growth Hormone Deficiency
1 trial -
armodafinil
Teva Pharma GmbH
Sleep Disorders
1 trial -
diclofenac sodium topical gel
Teva Pharma GmbH
Multiple Sclerosis
1 trial -
glatiramer acetate
Teva Pharma GmbH
Multiple Sclerosis
2 trials -
glatiramer acetate injection with oral cetirizine hydrochloride
Teva Pharma GmbH
Multiple Sclerosis
1 trial -
mycophenolate mofetil (Myfenax)
Teva Pharma GmbH
Stable Renal Transplant Recipients
1 trial -
Albuterol eMDPI DS
Teva Pharma GmbH
Pulmonary Disease, Chronic Obstructive
1 trial -
Armodafinil
Teva Pharma GmbH
Sleep Apnea
1 trial -
Azilect
Teva Pharma GmbH
Parkinson's Disease
1 trial -
Volcolon sugar free
Teva Pharma GmbH
Constipation
1 trial -
extrafine HFA-beclomethasone
Teva Pharma GmbH
Asthma
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources